(“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium (SABCS). “These data suggest ...
News
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination ... - StreetInsider
- SA's BioBridge Global to launch new subsidiary - San Antonio Business Journal
In a move expected to strengthen and expand San Antonio's standing in the international biotech arena, BioBridge Global plans to merge its cell ...
- BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - PR Newswire
Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium. MINNEAPOLIS, Dec. 10, 2024 /PRNewswire/ -- Bio-Techne ...
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of ...
These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Preliminary results from ...
- Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC ...
Zetagen will attend the upcoming San Antonio Breast Cancer Symposium (SABCS) and the JP Morgan Healthcare Conference. Post to LinkedIn · Share on ...